Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

<< Previous
Bullboard Posts
Next >>
Post by retiredcfon Jul 11, 2022 9:05am
168 Views
Post# 34814700

Globe & Mail

Globe & MailIt will be interesting to see if this finally gets the SP moving, particularly as it looks to be another down day in the markets. GLTA

07:38 AM EDT, 07/11/2022 (MT Newswires) -- OpSens Inc. (OPS.TO), a medical device cardiology-focused company, said Monday it has been awarded a national group purchasing agreement with Premier, Inc, a healthcare improvement company covering 4,400 U.S. hospitals and health systems. From July 1 , the new agreement allows Premier members to take advantage of special pricing and terms pre-negotiated by Premier for OptoWire III and related system components.

Louis Laflamme , President and CEO of OpSens, said, "Collaborations like this one are an integral part of our strategy to expand the commercialization of the OptoWire in the U.S. and internationally, by increasing our cath lab access. Importantly, OpSens now has contracts in place covering over 90% of hospitals in the U.S. through group purchasing agreements."

OpSens' OptoWire is a modern pressure guidewire designed to help in the diagnosis, treatment, and confirmation of results in coronary arteries. Among other features, the OptoWire allows navigation through complex anatomies and the delivery of a stent without guidewire exchange.

<< Previous
Bullboard Posts
Next >>